These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20958261)

  • 1. Apoptosis induction by thalidomide: critical for limb teratogenicity but therapeutic potential in idiopathic pulmonary fibrosis?
    Knobloch J; Jungck D; Koch A
    Curr Mol Pharmacol; 2011 Jan; 4(1):26-61. PubMed ID: 20958261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding light on an old mystery: thalidomide suppresses survival pathways to induce limb defects.
    Knobloch J; Rüther U
    Cell Cycle; 2008 May; 7(9):1121-7. PubMed ID: 18418038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway.
    Hansen JM; Harris C
    Antioxid Redox Signal; 2004 Feb; 6(1):1-14. PubMed ID: 14713331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway.
    Knobloch J; Shaughnessy JD; Rüther U
    FASEB J; 2007 May; 21(7):1410-21. PubMed ID: 17283219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell death.
    Knobloch J; Schmitz I; Götz K; Schulze-Osthoff K; Rüther U
    Mol Cell Biol; 2008 Jan; 28(2):529-38. PubMed ID: 18178729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misregulation of gene expression in the redox-sensitive NF-kappab-dependent limb outgrowth pathway by thalidomide.
    Hansen JM; Gong SG; Philbert M; Harris C
    Dev Dyn; 2002 Oct; 225(2):186-94. PubMed ID: 12242718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos.
    Mahony C; McMenemy S; Rafipay AJ; Beedie SL; Fraga LR; Gütschow M; Figg WD; Erskine L; Vargesson N
    J Anat; 2018 Apr; 232(4):568-574. PubMed ID: 29023763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.
    Knobloch J; Jungck D; Koch A
    Curr Mol Med; 2017; 17(2):108-117. PubMed ID: 28429672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of thalidomide in chicken embryos.
    Stephens TD
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):725-31. PubMed ID: 19645049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratogenic effects of thalidomide: molecular mechanisms.
    Ito T; Ando H; Handa H
    Cell Mol Life Sci; 2011 May; 68(9):1569-79. PubMed ID: 21207098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the mystery of thalidomide teratogenicity.
    Ito T; Handa H
    Congenit Anom (Kyoto); 2012 Mar; 52(1):1-7. PubMed ID: 22348778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The teratogenic effects of thalidomide on limbs.
    Vargesson N
    J Hand Surg Eur Vol; 2019 Jan; 44(1):88-95. PubMed ID: 30335598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aza-2'-deoxycytidine-induced cytotoxicity and limb reduction defects in the mouse.
    Rosen MB; Chernoff N
    Teratology; 2002 Apr; 65(4):180-90. PubMed ID: 11948564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide rescues thalidomide mediated teratogenicity.
    Siamwala JH; Veeriah V; Priya MK; Rajendran S; Saran U; Sinha S; Nagarajan S; Pradeep T; Chatterjee S
    Sci Rep; 2012; 2():679. PubMed ID: 22997553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesonephros has a role in limb development and is related to thalidomide embryopathy.
    Smith DM; Torres RD; Stephens TD
    Teratology; 1996 Sep; 54(3):126-34. PubMed ID: 8987155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide.
    Ema M; Ise R; Kato H; Oneda S; Hirose A; Hirata-Koizumi M; Singh AV; Knudsen TB; Ihara T
    Reprod Toxicol; 2010 Jan; 29(1):49-56. PubMed ID: 19751816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a primary target of thalidomide teratogenicity.
    Ito T; Ando H; Suzuki T; Ogura T; Hotta K; Imamura Y; Yamaguchi Y; Handa H
    Science; 2010 Mar; 327(5971):1345-50. PubMed ID: 20223979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental staging and thalidomide teratogenicity in the green monkey (Cercopithecus aethiops).
    Hendrickx AG; Sawyer RH
    Teratology; 1978 Dec; 18(3):393-404. PubMed ID: 105418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.
    Kavitha K; Kowshik J; Kishore TK; Baba AB; Nagini S
    Biochim Biophys Acta; 2013 Oct; 1830(10):4433-44. PubMed ID: 23726989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizer formation in Hydra is disrupted by thalidomide treatment.
    Brooun M; Manoukian A; Shimizu H; Bode HR; McNeill H
    Dev Biol; 2013 Jun; 378(1):51-63. PubMed ID: 23531412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.